View in EDS HTML Full Text PDF Full Text

Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.

Saved in:
Bibliographic Details
Title: Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
Authors: Tai CC; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Medwid S; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada., Mclntosh K; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Chande N; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Kim RB; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada., Gregor J; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.
Source: Journal of the Canadian Association of Gastroenterology [J Can Assoc Gastroenterol] 2024 Feb 10; Vol. 7 (3), pp. 238-245. Date of Electronic Publication: 2024 Feb 10 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101738684 Publication Model: eCollection Cited Medium: Internet ISSN: 2515-2092 (Electronic) Linking ISSN: 25152084 NLM ISO Abbreviation: J Can Assoc Gastroenterol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38841142
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tai+CC%22">Tai CC</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.<br /><searchLink fieldCode="AU" term="%22Medwid+S%22">Medwid S</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.<br /><searchLink fieldCode="AU" term="%22Mclntosh+K%22">Mclntosh K</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.<br /><searchLink fieldCode="AU" term="%22Chande+N%22">Chande N</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.<br /><searchLink fieldCode="AU" term="%22Kim+RB%22">Kim RB</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.<br /><searchLink fieldCode="AU" term="%22Gregor+J%22">Gregor J</searchLink>; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101738684%22">Journal of the Canadian Association of Gastroenterology</searchLink> [J Can Assoc Gastroenterol] 2024 Feb 10; Vol. 7 (3), pp. 238-245. <i>Date of Electronic Publication: </i>2024 Feb 10 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101738684 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2515-2092 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225152084%22">25152084 </searchLink><i>NLM ISO Abbreviation: </i>J Can Assoc Gastroenterol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38841142
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jcag/gwae005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 238
    Titles:
      – TitleFull: Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tai CC
      – PersonEntity:
          Name:
            NameFull: Medwid S
      – PersonEntity:
          Name:
            NameFull: Mclntosh K
      – PersonEntity:
          Name:
            NameFull: Chande N
      – PersonEntity:
          Name:
            NameFull: Kim RB
      – PersonEntity:
          Name:
            NameFull: Gregor J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2024 Feb 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2515-2092
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of the Canadian Association of Gastroenterology
              Type: main
ResultId 1